Regenesis Biomedical offers electromagnetic shortwave diathermy therapy devices intended for use by patients at home. The company serves the healthcare industry and provides support and services to veterans through direct VA partnerships. It was founded in 1996 and is based in Scottsdale, Arizona.

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Transcutaneous Technologies operates as a reputable bookmaker in the online entertainment sector, providing a platform for various forms of betting and gaming. The company offers a range of services including sports betting, online casino games, and lottery, catering to the gambling community without using overly technical language. Transcutaneous Technologies primarily serves the online gambling industry, offering products like live dealer games and slot machine games to enhance the user experience. It is based in Ohio, United States.

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

CryoPen is a company focused on advancing cryosurgical technology within the medical device industry. Its main offering is the CryoPen Surgical System, which employs linear compression cooling technology to perform cryosurgery using cryogenic gases or liquids. The system is designed for precision treatment of various skin lesions and pre-cancerous conditions, catering primarily to medical professionals in fields such as general practice, OB/GYN, podiatry, internal medicine, urology, and pediatrics. It was founded in 2005 and is based in Corpus Christi, Texas.

CleveX focuses on the development of medical devices within the healthcare sector. The company offers solutions for skin biopsy, along with associated processes designed for use in primary care, family medicine, obstetrics and gynecology, and dermatology practices. It was founded in 2003 and is based in Columbus, Ohio.